Drugs that need prior authorization
i
CMS's monthly Part D formulary files: for each plan, its formulary, and for each drug on the formulary, whether it needs prior authorization, step therapy or a quantity limit. A drug here is one RxNorm drug concept (an ingredient, strength and form); shares are of the drugs on the plan's formulary.
From October each year the files describe the next year's plans, which go on sale then, so a month-to-month change is shown only between months of the same plan year. Members: each plan's enrollment that month, or the latest month we have; for next year's plans, today's enrollment of the same contract and plan number, so new plans count zero until they have members. Contract and parent figures are member-weighted across their plans.
The share of drugs needing approval says how much of the list carries a restriction, not how often members meet one: a plan can restrict many rarely used drugs, or a few common ones.
Share of covered drugs needing prior authorization, by month
Member-weighted across plans. Each line is one plan year; next year's plans appear from October.
By plan: H1607, October 2026
| Plan | Members | Drugs on formulary | Prior authorizationshare of drugs | ChangeiChange Change in the share of drugs needing prior authorization since the month before (Sep), in percentage points. Only months of the same plan year are compared: October 2026 is the first month of the 2027 plan year, so there's nothing to compare yet. |
Step therapy | Quantity limit | Formulary |
|---|---|---|---|---|---|---|---|
| H1607-015 Anthem Medicare Advantage 2 (PPO)Elevance Health, Inc. | 6,716 | 3,538 | 29.2% | — | 0.2% | 45% | 00027020 |
| H1607-012 Anthem Medicare Advantage 3 (PPO)Elevance Health, Inc. | 1,274 | 3,538 | 29.2% | — | 0.2% | 45% | 00027020 |
Members are projected from todays enrollment.